BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patients
Titel:
BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patients
Auteur:
Faulkner, Rowena D. Craddock, Charles Byrne, Jennifer L. Mahendra, Prem Haynes, Andrew P. Prentice, Hugh G. Potter, Michael Pagliuca, Antonio Ho, Aloysius Devereux, Stephen McQuaker, Grant Mufti, Ghulam Yin, John Liu Russell, Nigel H.